Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24480850 | 0.93 | TSHR (0.32) | CHRM2CHRM3 | |
| SCHEMBL24480851 | 0.91 | KMT2A (0.32) | KMT2AOPRM1OPRL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL24480839 | 0.89 | KMT2A (0.33) | KMT2AHRH3OPRM1OPRL1 | |
| SCHEMBL27267682 | 0.88 | KMT2A (0.42) | KMT2ACHRM2CHRM3HRH3SMN1; SMN2 | |
| SCHEMBL13168226 | 0.85 | KMT2A (0.39) | KMT2AHRH3ALDH1A1SMN1; SMN2 | |
| SCHEMBL24480909 | 0.84 | TSHR (0.43) | KMT2AALDH1A1 | |
| SCHEMBL24480422 | 0.83 | SMN1; SMN2 (0.36) | KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL14996489 | 0.80 | ALDH1A1 (0.38) | HRH3ALDH1A1SMN1; SMN2 | |
| SCHEMBL27289186 | 0.80 | KMT2A (0.38) | KMT2A | |
| SCHEMBL25101130 | 0.78 | HRH3 (0.38) | HRH3OPRM1OPRL1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022111526-A1 | BENZENE RING DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | 四川海思科制药有限公司 | 2022-06-02 | — | — | WO | disclosed |